State Street’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-12,619,473
Closed -$2.68B 3757
2014
Q4
$2.68B Buy
12,619,473
+345,407
+3% +$68.7M 0.27% 81
2014
Q3
$2.19B Sell
12,274,066
-565,991
-4% -$94M 0.24% 91
2014
Q2
$2.17B Buy
12,840,057
+708,133
+6% +$110M 0.23% 87
2014
Q1
$1.51B Sell
12,131,924
-420,340
-3% -$51.2M 0.17% 126
2013
Q4
$1.39B Buy
12,552,264
+413,060
+3% +$39.5M 0.16% 141
2013
Q3
$1.1B Sell
12,139,204
-99,386
-0.8% -$8.92M 0.14% 159
2013
Q2
$1.03B Buy
+12,238,590
New +$1.27B 0.13% 154

Other funds holding AGN

State Street's AGN Position: Q1 2015 in Review

State Street sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 12,619,473 shares — an estimated $2.68B sold.

State Street first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $2.68B in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • State Street reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • State Street sold 12,619,473 Allergan Inc shares in Q1 2015, an estimated $2.68B.
  • State Street first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • State Street's Allergan Inc position peaked at $2.68B in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on State Street's 13F filing for Q1 2015, filed 15 May 2015.